Leerink Partners analyst Mike Kratky has maintained their bullish stance on ISRG stock, giving a Buy rating yesterday.Stay Ahead of the ...
15h
Six out of 31 total new small molecules approved by the FDA in 2024 were produced by Wuxi, said the company's co-CEO.
Eli Lilly stock undercut its 50-day line on Jan. 14 after cutting its fourth-quarter and 2024 outlook. Is LLY stock a sell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback